Portal de Periódicos da CAPES

An overview of current and emerging devices for percutaneous left atrial appendage closure

2018; Elsevier BV; Volume: 29; Issue: 4 Linguagem: Inglês

10.1016/j.tcm.2018.08.008

1873-2615

Danny H.F. Chow, Yam-Hong Wong, Jai‐Wun Park, Yat‐Yin Lam, Tom De Potter, Josep Rodés‐Cabau, Lluís Asmarats, Marcus Sandri, Eleftherios B. Sideris, Trevor McCaw, Randall J. Lee, Horst Sievert, Lars Søndergaard, Ole De Backer,

Cardiac pacing and defibrillation studies

Atrial fibrillation (AF) is common and is a prominent risk factor for ischemic stroke. Oral anticoagulant (OAC) therapy has been the main strategy for stroke prevention in AF patients; however, OAC therapy carries a bleeding risk and is not tolerated by all patients. Left atrial appendage (LAA) closure offers a non-pharmacological alternative for stroke prevention in patients with non-valvular AF. In this update, an overview of current and emerging LAA occluders is given - with special attention to the key design features of every single device and, if available, preclinical or clinical data.